BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The market for orphan drug products continues to expand and de
 veloping new treatments for rare diseases is becoming an increasingly imp
 ortant growth area for many pharmaceutical companies. This interest in ra
 re and orphan diseases is linked not only to the incentives offered by th
 e different regulatory authorities but also to the recent development of 
 advanced therapies.\n\nThe interactive course will cover all the key aspe
 cts of orphan drug legislation in both the US and EU and the regulatory p
 rocesses designed to enable early access to innovative medicines. The pro
 gramme will help you to assess the strategic considerations of when to ap
 ply for orphan designation and to which agency and look at the developmen
 t of advanced therapies and using orphan drug designation with your ATMP 
 strategy.\n\nA case study session on how to prepare and manage an orphan 
 drug submission will consolidate learning and ensure that you leave the e
 vent with practical skills and knowledge that can be put to use in the wo
 rkplace. The course will allow you not only to learn from our expert trai
 ner but also to share the experiences of other delegates.\n
DTEND:20210310T170000
DTSTAMP:20260512T232625Z
DTSTART:20210310T090000
LOCATION:\,
SEQUENCE:0
SUMMARY:The market for orphan drug products continues to expand and develo
 ping new treatments for rare diseases is becoming an increasingly importa
 nt growt...
UID:7bae1d7b-03a2-4b34-807c-1b8efa495f97
END:VEVENT
END:VCALENDAR